681 filings
Page 3 of 35
8-K
a377ym6
12 May 23
Ani Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
4:56pm
8-K
9mgepze0f52u8j
11 May 23
Ani Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:02pm
424B5
67nogfdkk f5ddj45
11 May 23
Prospectus supplement for primary offering
4:01pm
DEFA14A
gzm4qlbw8a
8 May 23
Additional proxy soliciting materials
8:35am
8-K
6pnzh3o1an74
8 May 23
Departure of Directors or Certain Officers
8:33am
8-K
7xakw3ns0cwbr9s7kmdm
8 May 23
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
8:31am
DEFA14A
3eo1d
11 Apr 23
Additional proxy soliciting materials
4:36pm
ARS
jlvtnmst 66o0b
11 Apr 23
Annual report to shareholders
4:32pm
8-K
c5fi281hhixw1q4nt4
10 Mar 23
Regulation FD Disclosure
4:28pm
8-K
8udjr kgzaag2c69
9 Mar 23
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
7:02am
8-K
2u70tzffdxk sp9
6 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
CT ORDER
oiwj fc4f0ptabd
22 Feb 23
Confidential treatment order
9:33am
UPLOAD
i5zc2mper
30 Jan 23
Letter from SEC
12:00am
CORRESP
qp1h0
27 Jan 23
Correspondence with SEC
12:00am
CORRESP
a5jf2 etqp
6 Jan 23
Correspondence with SEC
12:00am
UPLOAD
99sx8 rode1qzav7
12 Dec 22
Letter from SEC
12:00am
CORRESP
qlu50 cdz122
5 Dec 22
Correspondence with SEC
12:00am